Pliant Therapeutics, Inc. posts $-0.12 million annual loss
By USInMinutes
Published - Mar 12, 2023, 05:05 PM ET
Last Updated - Jul 18, 2023, 04:20 PM EDT
Pliant Therapeutics, Inc. [PLRX] has posted annual loss of $-0.12 million for the year ended Dec 31,2022.
The company based in California(CA)reported a fellin revenue to $097 milion for the year when compared to $7.57 million in the previous year.
A filing from the company with the Securities and Exchange Commission on Mar 9,2023 showed that its revenue is up 99.87% year-over-year.
The company reported basic earnings per share of $42015908 and diluted earnings per share of $42015908.
Pliant Therapeutics, Inc. operates in the Pharmaceutical Preparations sector.
Related News
➤Pliant Therapeutics Announces Appointments of Darren Cline and Thomas McCourt to Board of Directors
--------
NewsInMinutes: is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts.